color=#900000>Within the Herpes and Respiratory Antiviral Subcategory HSV/VZV
Products have been Key Growth Drivers, Accounting for 77% of a Market Worth
$2,190m in 2004

Research and Markets
(researchandmarkets.com/reports/c28099) has announced the addition of Herpes and
Respiratory Antivirals - Leaders Rise and Fall to their offering.